Global Transcatheter Aortic Valve Implantation (TAVI) Market

Transcatheter Aortic Valve Implantation (TAVI) Comprehensive Study by Type (Transfemoral Implantation, Transapical Implantation, Transaortic Implantation), Application (Hospitals & Clinics, Academic and Research Institutes) Players and Region - Global Market Outlook to 2030

Transcatheter Aortic Valve Implantation (TAVI) Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 12.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Transcatheter Aortic Valve Implantation (TAVI)
Transcatheter aortic valve implantation (TAVI) is a minimally invasive heart procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis). Transcatheter aortic valve replacement is sometimes called Transcatheter aortic valve replacement (TAVR). TAVI involves the implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need for transcatheter aortic valve implantation is on the rise due to the increase in the prevalence of aortic stenosis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR12.8%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Transcatheter Aortic Valve Implantation (TAVI) market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boston Scientific (United States), Direct Flow medical (United States), Edwards Lifesciences Corporation (United States), Jenavalve Technology (Germany), Medtronic (Ireland), Meril Life Sciences (India), St. Jude Medical (United States), SYMETIS (Switzerland) and Transcatheter Technologies (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Transcatheter Aortic Valve Implantation (TAVI) market by Type (Transfemoral Implantation, Transapical Implantation and Transaortic Implantation), Application (Hospitals & Clinics and Academic and Research Institutes) and Region.



On the basis of geography, the market of Transcatheter Aortic Valve Implantation (TAVI) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Transcatheter Aortic Valve Implantation (TAVI) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Funding for Research & Development Activities

Market Growth Drivers:
Rise in Prevalence of Aortic Stenosis coupled with Increase in Geriatric Population and Increase in Adoption rate for Transcatheter Aortic Valve Implantation Procedure

Challenges:
Stringent Regulatory Approval Process

Restraints:
High Cost of the Device and Unfavorable Reimbursement Policies

Opportunities:
Use of TAVI Systems for New Indications and Rise in Healthcare Expenditure of Developing countries

Market Leaders and their expansionary development strategies
In June 2020, Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the Evolut™ Transcatheter Aortic Valve Implantation (TAVI) system for patients with severe native aortic stenosis who are at a low risk of surgical mortality. The Evolut TAVI platform also received a new indication approval that allows for the treatment of patients with bicuspid aortic valves who are at intermediate, high and extreme risk of surgical mortality. and In May 2018, Abbott announced treatment with the company's Portico™ transcatheter aortic valve replacement (TAVR) therapy was associated with excellent clinical outcomes at 30 days, including low rates of death, disabling stroke, and paravalvular leak. Additional benefits observed included a reduction in New York Heart Association (NYHA) class severity, low rates of bleeding, and improvements in a six-minute walk test, allowing patients to return to their previous lifestyles and activity faster.
In December, 2022, Global healthcare company, Abbott has launched its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor. The Navitor TAVI system is the latest addition to the company's comprehensive structural heart transcatheter portfolio that offers physicians and patients less invasive options to treat heart diseases.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation
By Application
  • Hospitals & Clinics
  • Academic and Research Institutes
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Prevalence of Aortic Stenosis coupled with Increase in Geriatric Population
      • 3.2.2. Increase in Adoption rate for Transcatheter Aortic Valve Implantation Procedure
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Approval Process
    • 3.4. Market Trends
      • 3.4.1. Increasing Funding for Research & Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transcatheter Aortic Valve Implantation (TAVI), by Type, Application and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Transcatheter Aortic Valve Implantation (TAVI) (Value)
      • 5.2.1. Global Transcatheter Aortic Valve Implantation (TAVI) by: Type (Value)
        • 5.2.1.1. Transfemoral Implantation
        • 5.2.1.2. Transapical Implantation
        • 5.2.1.3. Transaortic Implantation
      • 5.2.2. Global Transcatheter Aortic Valve Implantation (TAVI) by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Academic and Research Institutes
      • 5.2.3. Global Transcatheter Aortic Valve Implantation (TAVI) Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Transcatheter Aortic Valve Implantation (TAVI) (Price)
      • 5.3.1. Global Transcatheter Aortic Valve Implantation (TAVI) by: Type (Price)
  • 6. Transcatheter Aortic Valve Implantation (TAVI): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Direct Flow medical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Edwards Lifesciences Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jenavalve Technology (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medtronic (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Meril Life Sciences (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. St. Jude Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SYMETIS (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Transcatheter Technologies (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Transcatheter Aortic Valve Implantation (TAVI) Sale, by Type, Application and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Transcatheter Aortic Valve Implantation (TAVI) (Value)
      • 7.2.1. Global Transcatheter Aortic Valve Implantation (TAVI) by: Type (Value)
        • 7.2.1.1. Transfemoral Implantation
        • 7.2.1.2. Transapical Implantation
        • 7.2.1.3. Transaortic Implantation
      • 7.2.2. Global Transcatheter Aortic Valve Implantation (TAVI) by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Academic and Research Institutes
      • 7.2.3. Global Transcatheter Aortic Valve Implantation (TAVI) Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Transcatheter Aortic Valve Implantation (TAVI) (Price)
      • 7.3.1. Global Transcatheter Aortic Valve Implantation (TAVI) by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transcatheter Aortic Valve Implantation (TAVI): by Type(USD Million)
  • Table 2. Transcatheter Aortic Valve Implantation (TAVI) Transfemoral Implantation , by Region USD Million (2018-2023)
  • Table 3. Transcatheter Aortic Valve Implantation (TAVI) Transapical Implantation , by Region USD Million (2018-2023)
  • Table 4. Transcatheter Aortic Valve Implantation (TAVI) Transaortic Implantation , by Region USD Million (2018-2023)
  • Table 5. Transcatheter Aortic Valve Implantation (TAVI): by Application(USD Million)
  • Table 6. Transcatheter Aortic Valve Implantation (TAVI) Hospitals & Clinics , by Region USD Million (2018-2023)
  • Table 7. Transcatheter Aortic Valve Implantation (TAVI) Academic and Research Institutes , by Region USD Million (2018-2023)
  • Table 8. South America Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2018-2023)
  • Table 9. South America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 10. South America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 11. Brazil Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 12. Brazil Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 13. Argentina Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 14. Argentina Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 15. Rest of South America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 16. Rest of South America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 20. China Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 21. China Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 22. Japan Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 23. Japan Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 24. India Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 25. India Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 26. South Korea Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 27. South Korea Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 28. Taiwan Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 29. Taiwan Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 30. Australia Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 31. Australia Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 34. Europe Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2018-2023)
  • Table 35. Europe Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 36. Europe Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 37. Germany Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 38. Germany Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 39. France Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 40. France Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 41. Italy Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 42. Italy Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 43. United Kingdom Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 44. United Kingdom Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 45. Netherlands Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 46. Netherlands Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 49. MEA Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2018-2023)
  • Table 50. MEA Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 51. MEA Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 52. Middle East Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 53. Middle East Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 54. Africa Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 55. Africa Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 56. North America Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2018-2023)
  • Table 57. North America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 58. North America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 59. United States Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 60. United States Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 61. Canada Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 62. Canada Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 63. Mexico Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2018-2023)
  • Table 64. Mexico Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2018-2023)
  • Table 65. Transcatheter Aortic Valve Implantation (TAVI): by Type(USD/Units)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Transcatheter Aortic Valve Implantation (TAVI): by Type(USD Million)
  • Table 76. Transcatheter Aortic Valve Implantation (TAVI) Transfemoral Implantation , by Region USD Million (2025-2030)
  • Table 77. Transcatheter Aortic Valve Implantation (TAVI) Transapical Implantation , by Region USD Million (2025-2030)
  • Table 78. Transcatheter Aortic Valve Implantation (TAVI) Transaortic Implantation , by Region USD Million (2025-2030)
  • Table 79. Transcatheter Aortic Valve Implantation (TAVI): by Application(USD Million)
  • Table 80. Transcatheter Aortic Valve Implantation (TAVI) Hospitals & Clinics , by Region USD Million (2025-2030)
  • Table 81. Transcatheter Aortic Valve Implantation (TAVI) Academic and Research Institutes , by Region USD Million (2025-2030)
  • Table 82. South America Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2025-2030)
  • Table 83. South America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 84. South America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 85. Brazil Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 86. Brazil Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 87. Argentina Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 88. Argentina Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 89. Rest of South America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 90. Rest of South America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 91. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2025-2030)
  • Table 92. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 93. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 94. China Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 95. China Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 96. Japan Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 97. Japan Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 98. India Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 99. India Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 100. South Korea Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 101. South Korea Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 102. Taiwan Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 103. Taiwan Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 104. Australia Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 105. Australia Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 106. Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 108. Europe Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2025-2030)
  • Table 109. Europe Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 110. Europe Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 111. Germany Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 112. Germany Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 113. France Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 114. France Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 115. Italy Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 116. Italy Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 117. United Kingdom Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 118. United Kingdom Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 119. Netherlands Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 120. Netherlands Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 121. Rest of Europe Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 122. Rest of Europe Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 123. MEA Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2025-2030)
  • Table 124. MEA Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 125. MEA Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 126. Middle East Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 127. Middle East Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 128. Africa Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 129. Africa Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 130. North America Transcatheter Aortic Valve Implantation (TAVI), by Country USD Million (2025-2030)
  • Table 131. North America Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 132. North America Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 133. United States Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 134. United States Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 135. Canada Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 136. Canada Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 137. Mexico Transcatheter Aortic Valve Implantation (TAVI), by Type USD Million (2025-2030)
  • Table 138. Mexico Transcatheter Aortic Valve Implantation (TAVI), by Application USD Million (2025-2030)
  • Table 139. Transcatheter Aortic Valve Implantation (TAVI): by Type(USD/Units)
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transcatheter Aortic Valve Implantation (TAVI): by Type USD Million (2018-2023)
  • Figure 5. Global Transcatheter Aortic Valve Implantation (TAVI): by Application USD Million (2018-2023)
  • Figure 6. South America Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 7. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 8. Europe Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 9. MEA Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 10. North America Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 11. Global Transcatheter Aortic Valve Implantation (TAVI): by Type USD/Units (2018-2023)
  • Figure 12. Global Transcatheter Aortic Valve Implantation (TAVI) share by Players 2023 (%)
  • Figure 13. Global Transcatheter Aortic Valve Implantation (TAVI) share by Players (Top 3) 2023(%)
  • Figure 14. Global Transcatheter Aortic Valve Implantation (TAVI) share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 17. Boston Scientific (United States) Revenue: by Geography 2023
  • Figure 18. Direct Flow medical (United States) Revenue, Net Income and Gross profit
  • Figure 19. Direct Flow medical (United States) Revenue: by Geography 2023
  • Figure 20. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2023
  • Figure 22. Jenavalve Technology (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Jenavalve Technology (Germany) Revenue: by Geography 2023
  • Figure 24. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 26. Meril Life Sciences (India) Revenue, Net Income and Gross profit
  • Figure 27. Meril Life Sciences (India) Revenue: by Geography 2023
  • Figure 28. St. Jude Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. St. Jude Medical (United States) Revenue: by Geography 2023
  • Figure 30. SYMETIS (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. SYMETIS (Switzerland) Revenue: by Geography 2023
  • Figure 32. Transcatheter Technologies (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Transcatheter Technologies (Germany) Revenue: by Geography 2023
  • Figure 34. Global Transcatheter Aortic Valve Implantation (TAVI): by Type USD Million (2025-2030)
  • Figure 35. Global Transcatheter Aortic Valve Implantation (TAVI): by Application USD Million (2025-2030)
  • Figure 36. South America Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 37. Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 38. Europe Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 39. MEA Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 40. North America Transcatheter Aortic Valve Implantation (TAVI) Share (%), by Country
  • Figure 41. Global Transcatheter Aortic Valve Implantation (TAVI): by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Boston Scientific (United States)
  • Direct Flow medical (United States)
  • Edwards Lifesciences Corporation (United States)
  • Jenavalve Technology (Germany)
  • Medtronic (Ireland)
  • Meril Life Sciences (India)
  • St. Jude Medical (United States)
  • SYMETIS (Switzerland)
  • Transcatheter Technologies (Germany)
Select User Access Type

Key Highlights of Report


Apr 2024 169 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transcatheter Aortic Valve Implantation (TAVI) Market Quantitative research analysis
Global Transcatheter Aortic Valve Implantation (TAVI) Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boston Scientific (United States), Direct Flow medical (United States), Edwards Lifesciences Corporation (United States), Jenavalve Technology (Germany), Medtronic (Ireland), Meril Life Sciences (India), St. Jude Medical (United States), SYMETIS (Switzerland) and Transcatheter Technologies (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Funding for Research & Development Activities" is seen as one of major influencing trends for Transcatheter Aortic Valve Implantation (TAVI) Market during projected period 2023-2030.
The Transcatheter Aortic Valve Implantation (TAVI) market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Transcatheter Aortic Valve Implantation (TAVI) Market Report?

Have a Query? Click Here

Other Related Reports

Head Lice Infestation Treatment Comprehensive Study by Type (Lotion, Creams, Shampoo), Treatment Type (Topical Pediculicides (Malathion, Permethrin), Wet Combing, Oral Therapy), End User (Childrens, ...
$ 3500
Nutrigenomics Testing Comprehensive Study by Application (Obesity, Diabetes, Cardiovascular Diseases, Cancer Research, Women's Health, Neurological, Others), Distribution Channel (Hospitals & Clinics...
$ 3500
Ayurveda Comprehensive Study by Application (Gastrointestinal Diseases, Cardiac Disorders, Respiratory Disorders, Psychological Disorders, Movement Disorders, Others), Treatment (Vamana, Virechana, N...
$ 3650
Single Cell Isolation Systems Comprehensive Study by Type (Flow Cytometry Systems, Microfluidic Systems, Laser Microdissection Systems, Others), Application (Drug Discovery, Life Science Research, Ot...
$ 3450
Elderly Care Facilities Comprehensive Study by Type (Pharmaceuticals, Housing and Assistive Devices), Application (Heart Diseases, Cancer, Kidney Diseases, Diabetes, Arthritis, Osteoporosis, Neurolog...
$ 3750
Hematology Therapies Comprehensive Study by Type (Instruments, Consumable), Application (Physiology, Pathology, Etiology, Diagnosis, Treatment, Prognosis), Blood Disorder Type (Hemophilia, Leukemia, ...
$ 3650